Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
18 May, 2026, 10.31 PM IST
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
29 Apr, 2026, 02.22 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
13 Apr, 2026, 11.14 PM IST
I-Sec upgrades GlaxoSmithKline Pharma to Add, lowers target price to Rs 2,250ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma's...
19 Feb, 2025, 09.51 AM IST
CCI approves Corona Remedies-GlaxoSmithKline dealDilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona Remedies along with trademark and goodwill.
07 Mar, 2017, 11.13 PM IST
GlaxoSmithKline Consumer Healthcare Ltd India-Novartis deal won't affect business in IndiaGlaxoSmithKline Consumer Healthcare today said the global deal between GlaxoSmithKline Plc and Novartis won't affect its business in India.
22 Apr, 2014, 05.44 PM IST
GSK Pharma shares slump over 8% ahead of closure of open offerShares of GlaxoSmithKline Pharmaceuticals slumped over 8 per cent as the open offer made by its UK-based parent to acquire additional stake...
05 Mar, 2014, 06.05 PM IST
GSK gets FIPB nod to buy 24.33% more in indian armThe Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33%stake, or 2.06 crore, equity shares in GlaxoSmithKline Pharmace...
14 Jan, 2014, 04.00 AM IST
Page, Eicher Motors and Glaxo Consumer to do well on earnings uptick: Manish SonthaliaPage, Eicher Motors and Glaxo Consumer to do well on earnings uptick, says Manish Sonthalia.
08 Jan, 2014, 12.38 PM IST
GlaxoSmithKline seeks FIPB nod to hike stake in Indian armGlaxoSmithKline has approached the FIPB to hike stake in its domestic arm by buying 24.33 per cent for an estimated Rs 6,400 crore.
05 Jan, 2014, 11.35 AM IST
GSK's open offer for buying stake in Indian arm from February 7-21GlaxoSmithKline Plc's Rs 6,389.02 crore open offer to pick up 24.33 per cent stake in its Indian arm GlaxoSmithKline Pharma will start from...
24 Dec, 2013, 04.32 PM IST
Time to hold on Nestle, Glaxo and Colgate: Mehraboon IraniNestle, Glaxo consumer and Colgate belong to the same great super companies and the biggest positive for the stocks is that nobody sells th...
27 Nov, 2013, 04.33 PM IST
- GSK Consumer hits record high on parent company's plan to raise its stake
GSK Consumer surged 20% to hit its record high in early trade after its parent plans to raise its stake in Indian arm to 75%.
26 Nov, 2012, 10.11 AM IST
- Glaxo buys stake in South Africa's Aspen
GlaxoSmithKline PLC said that it is buying a 16 pc stake in South Africa's Aspen Pharmacare Holdings, giving Aspen the right to distribute ...
12 May, 2009, 04.05 PM IST
- GlaxoSmithKline announces Rs 31 per share dividend
GlaxoSmithKline Pharmaceuticals on Tuesday declared a dividend of Rs 17 per share for the year ended December 31, 2006 and a special additi...
29 May, 2007, 10.45 PM IST
- SC reserves judgement on GSK plea for Rosiglitazone
The Supreme Court on Tuesday reserved its judgement on pharma major GlaxoSmithKline Plc's petition seeking grant of exclusive marketing rig...
08 May, 2007, 08.38 PM IST